Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 10/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 9/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | ALOX5AP | P20292 | 4/20 | 0.41 |
| ▸ | FEN1 | P39748 | 3/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.40 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.40 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.40 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.40 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.40 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3215721 | 1.00 | OPRK1 (0.48) | OPRK1OPRM1ALOX15ALOX5APFEN1 | |
| SCHEMBL3224264 | 0.82 | OPRK1 (0.66) | OPRK1OPRM1ALOX5APFEN1KCNH2 | |
| SCHEMBL3224254 | 0.82 | OPRK1 (0.66) | OPRK1OPRM1ALOX5APFEN1KCNH2 | |
| SCHEMBL28969716 | 0.82 | ALOX15 (0.54) | OPRK1OPRM1ALOX15PSEN1PSEN2 | |
| SCHEMBL3219561 | 0.80 | OPRM1 (0.64) | OPRK1OPRM1ALOX5APFEN1KCNH2 | |
| SCHEMBL25171307 | 0.79 | PSEN1 (0.62) | ACHEPSEN1PSEN2APH1BNCSTN | |
| SCHEMBL29010641 | 0.79 | OPRK1 (0.49) | OPRK1OPRM1ALOX15ALOX5APFEN1 | |
| SCHEMBL3213443 | 0.78 | OPRK1 (0.77) | OPRK1OPRM1KCNH2 | |
| SCHEMBL3219508 | 0.78 | OPRK1 (0.77) | OPRK1OPRM1KCNH2 | |
| SCHEMBL3219520 | 0.78 | OPRK1 (0.77) | OPRK1OPRM1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100035873-A1 | Diaryl Compounds and Uses Thereof | PFIZER INC | 2010-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100035873-A1 | Diaryl Compounds and Uses Thereof | OPRK1, OPRD1, OPRL1 | OPRK1 1/4885OPRM1 4/4885ALOX15 2226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.